Vertex Pharmaceuticals (VRTX34.SA) Q4 2013 Earnings

29OctConfirmed
Q1 1
Q3 2013
Q4 2013
-1.18
1.57
4.31
7.06

Details

Expected EPS
N/A
Actual EPS
-1.17828
Surprise EPS
-1.18
Surprise Percent
+∞%

Description

Vertex Pharmaceuticals (VRTX34.SA) has reported earnings of -1.17828 per share for Q4 2013.

0 Comments

Share your thoughts